Key Highlights
•
A new review examines how a framework called Public Health Critical Race Praxis (PHCRP) can be used to guide the development and evaluation of real-world antiracism interventions in communities and healthcare settings. This is a crucial step toward moving from documenting the health impacts of racism to creating and testing actionable solutions to reduce health inequities.
Source →
•
The review finds that while evidence links racism to poor health, there is very little research providing data on how to effectively implement antiracism programs, highlighting a major gap between theory and practice. This assessment provides a starting point to support future, evidence-based efforts to mitigate racism’s effects on public health.
Source →
•
A case report underscores that Helicobacter pylori infection should be considered in children with a fever of unknown origin, especially if they have recently traveled to regions where the infection is common. This is important because the infection can cause significant illness in children but often presents with vague symptoms, leading to delayed diagnosis and treatment.
Source →
•
The report describes a child who had fever, weight loss, and anemia, and the cause remained a mystery until testing finally identified H. pylori. This case highlights a diagnostic challenge in pediatrics and reminds doctors to include this bacterial infection in their list of possible causes for prolonged fever.
Source →
•
A study comparing cell and gene therapy regulation and payment systems finds that the United States uses a market-driven model with commercial insurance, while China employs a government-led model through national medical insurance. Understanding these different approaches is key to addressing global challenges like high costs and unequal access to these advanced treatments.
Source →
•
Both countries face similar problems, including a lack of long-term safety data and difficulties making these expensive therapies widely available. The study suggests solutions like adaptable regulations and international payment partnerships to help more patients around the world benefit from these cutting-edge therapies.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
